Emem Iwara

Datos Biográficos

ID7848759
NOMBREEmem Iwara
NOMBRESEmem
APELLIDOIwara
FIRMAIWARA E
AFILIACIONESUniversity of Maryland, Baltimore
ORCID0000-0001-8826-1464
VERIFICADOSí
TOTAL DE OBRAS5
TOTAL DE CITAS0
TOTAL COMO AUTOR5
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2021
AÑO MÁS RECIENTE DE PUBLICACIÓN2023
ÍNDICE H0

  • Implementation of data triangulation and dashboard development for Covid-19 vaccine adverse event following immunisation (Aefi) data in Nigeria

    Open AccessTalya Shragai, Oluwasegun Joel Adegoke et al.ARTICLEBMJ Global Health2023

    Nigeria began administering COVID-19 vaccines on 5 March 2021 and is working towards the WHO’s African regional goal to fully vaccinate 70% of their eligible population by December 2022. Nigeria’s COVID-19 vaccination information system includes a surveillance system for COVID-19 adverse events following immunisation (AEFI), but as of April 2021, AEFI data were being collected and managed by multiple groups and lacked routine analysis and use for…

  • Assessing the impact of the Covid-19 restrictions on HIV testing services in Malawi

    Open AccessBarinaadaa Afirima, Ihoghosa Iyamu et al.ARTICLEAfrican Journal of AIDS Research2023

    Background : Restrictions on public gatherings and movement to mitigate the spread of COVID-19 may have disrupted access and availability of HIV services in Malawi. We quantified the impact of these restrictions on HIV testing services in Malawi. Methods : We conducted an interrupted time series analysis of routine aggregated programme data from 808 public and private, adult and paediatric health facilities across rural and urban communities in M…

  • Seroprevalence of Sars-CoV-2 in four states of Nigeria in October 2020

    Open AccessRosemary Audu, Kristen A Stafford et al.ARTICLEPLOS Global Public Health2022

    The observed epidemiology of SARS-CoV-2 in sub-Saharan Africa has varied greatly from that in Europe and the United States, with much lower reported incidence. Population-based studies are needed to estimate true cumulative incidence of SARS-CoV-2 to inform public health interventions. This study estimated SARS-CoV-2 seroprevalence in four selected states in Nigeria in October 2020. We implemented a two-stage cluster sample household survey in fo…

  • Covid-19 mortality rate and its associated factors during the first and second waves in Nigeria

    Open AccessKelly Elimian, Anwar Musah et al.ARTICLEPLOS Global Public Health2022

    COVID-19 mortality rate has not been formally assessed in Nigeria. Thus, we aimed to address this gap and identify associated mortality risk factors during the first and second waves in Nigeria. This was a retrospective analysis of national surveillance data from all 37 States in Nigeria between February 27, 2020, and April 3, 2021. The outcome variable was mortality amongst persons who tested positive for SARS-CoV-2 by Reverse-Transcriptase Poly…

  • Epidemiological comparison of the first and second waves of the Covid-19 pandemic in Nigeria, February 2020–April 2021

    Open AccessOluwatosin Akande, Kelly Elimian et al.ARTICLEBMJ Global Health2021

    BACKGROUND: With reports of surges in COVID-19 case numbers across over 50 countries, country-level epidemiological analysis is required to inform context-appropriate response strategies for containment and mitigation of the outbreak. We aimed to compare the epidemiological features of the first and second waves of COVID-19 in Nigeria. METHODS: We conducted a retrospective analysis of the Surveillance Outbreak Response Management and Analysis Sys…